High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India

Background/Aims The data on the risk of tuberculosis (TB) reactivation with infliximab (IFX) in patients with inflammatory bowel disease (IBD) from TB endemic countries, like India, is limited. The risk of TB reactivation on IFX and its predictors in patients with IBD was assessed. Methods This retr...

Full description

Bibliographic Details
Main Authors: Ashish Agarwal, Saurabh Kedia, Saransh Jain, Vipin Gupta, Sawan Bopanna, Dawesh P Yadav, Sandeep Goyal, Venigalla Pratap Mouli, Rajan Dhingra, Govind Makharia, Vineet Ahuja
Format: Article
Language:English
Published: Korean Association for the Study of Intestinal Diseases 2018-10-01
Series:Intestinal Research
Subjects:
Colitis, ulcerative
Crohn disease
Latent tuberculosis
Mantoux
Interferon-gamma release tests
Online Access:http://www.irjournal.org/upload/pdf/ir-2018-00023.pdf

Similar Items

Similar Items